Skip to main content
Top
Published in: Abdominal Radiology 9/2019

01-09-2019 | Hepatobiliary

Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy

Authors: Chenyang Zhan, Sonja Olsen, Hoi Cheung Zhang, Stephan Kannengiesser, Hersh Chandarana, Krishna Prasad Shanbhogue

Published in: Abdominal Radiology | Issue 9/2019

Login to get access

Abstract

Purpose

To compare qualitative results obtained from computer-aided dual-ratio analysis on T1-weighted two-point Dixon, with T2*-corrected multi-echo Dixon and T2-corrected multi-echo single-voxel MR spectroscopy sequence (MRS) for evaluation of liver fat and iron at 3T.

Methods and materials

This retrospective, HIPAA-compliant, IRB-approved study included 479 patients with known or suspected liver disease. Two-point Dixon, multi-echo Dixon, and MR spectroscopy sequences were performed for each patient at 3T. A receiver-operating characteristic analysis was performed to compare the diagnostic performance in 80 patients using biopsy as the standard. Sensitivity, specificity, PPV, and NPV of qualitative two-point Dixon results, multi-echo Dixon (PDFF and R2*), and MRS (fat fraction and R2 water) for detection of hepatic steatosis and siderosis were assessed.

Results

Fat fractions obtained from MRS and multi-echo Dixon have equivalent accuracy for detection of hepatic steatosis (AUC, sensitivity and specificity: 0.90 vs 0.88, 0.77 vs. 0.82, and 0.90 vs. 0.82), but the optimal cutoff value is higher for MRS (6.05% vs. 3.4%). The dual-ratio Dixon discrimination technique showed high negative predictive value for detection of hepatic steatosis and siderosis (0.90 and 0.94, respectively). R2* from multi-echo Dixon and R2water from MRS have equivalent accuracy for detection of iron overload at 3T (AUC 0.89 vs. 0.88). The optimal cutoff for R2* and R2water are 60.5 s−1 and 40.85 s−1, respectively.

Conclusion

The computer-aided dual-ratio discrimination with two-point Dixon is a useful qualitative screening tool with high negative predictive value for hepatic steatosis and iron overload. Multi-echo Dixon and MRS have similar accuracy for detection of hepatic steatosis and iron overload at 3 Tesla.
Literature
1.
go back to reference European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 64(6): p. 1388-402.CrossRef European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 64(6): p. 1388-402.CrossRef
2.
go back to reference Younossi, Z.M., M. Stepanova, M. Afendy, Y. Fang, Y. Younossi, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol, 9(6): p. 524-530 e1; quiz e60. Younossi, Z.M., M. Stepanova, M. Afendy, Y. Fang, Y. Younossi, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol, 9(6): p. 524-530 e1; quiz e60.
3.
go back to reference Browning, J.D., L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40(6): p. 1387-95.CrossRefPubMed Browning, J.D., L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40(6): p. 1387-95.CrossRefPubMed
4.
go back to reference Ratziu, V., F. Charlotte, A. Heurtier, S. Gombert, P. Giral, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology, 128(7): p. 1898-906.CrossRefPubMed Ratziu, V., F. Charlotte, A. Heurtier, S. Gombert, P. Giral, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology, 128(7): p. 1898-906.CrossRefPubMed
5.
go back to reference Van Beers, B.E., P. Garteiser, B. Leporq, P.E. Rautou, and D. Valla (2017) Quantitative Imaging in Diffuse Liver Diseases. Semin Liver Dis, 37(3): p. 243-258.CrossRefPubMed Van Beers, B.E., P. Garteiser, B. Leporq, P.E. Rautou, and D. Valla (2017) Quantitative Imaging in Diffuse Liver Diseases. Semin Liver Dis, 37(3): p. 243-258.CrossRefPubMed
6.
go back to reference Pineda, N., P. Sharma, Q. Xu, X. Hu, M. Vos, et al. (2009) Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy–a rapid and accurate technique. Radiology, 252(2): p. 568-76.CrossRefPubMed Pineda, N., P. Sharma, Q. Xu, X. Hu, M. Vos, et al. (2009) Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy–a rapid and accurate technique. Radiology, 252(2): p. 568-76.CrossRefPubMed
7.
go back to reference Yu, H., C.A. McKenzie, A. Shimakawa, A.T. Vu, A.C. Brau, et al. (2007) Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging, 26(4): p. 1153-61.CrossRefPubMed Yu, H., C.A. McKenzie, A. Shimakawa, A.T. Vu, A.C. Brau, et al. (2007) Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging, 26(4): p. 1153-61.CrossRefPubMed
8.
go back to reference Yu, H., A. Shimakawa, C.A. McKenzie, E. Brodsky, J.H. Brittain, et al. (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med, 60(5): p. 1122-34.CrossRefPubMedPubMedCentral Yu, H., A. Shimakawa, C.A. McKenzie, E. Brodsky, J.H. Brittain, et al. (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med, 60(5): p. 1122-34.CrossRefPubMedPubMedCentral
9.
go back to reference Bydder, M., T. Yokoo, G. Hamilton, M.S. Middleton, A.D. Chavez, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging, 26(3): p. 347-59.CrossRefPubMedPubMedCentral Bydder, M., T. Yokoo, G. Hamilton, M.S. Middleton, A.D. Chavez, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging, 26(3): p. 347-59.CrossRefPubMedPubMedCentral
10.
go back to reference Kuhn, J.P., D. Hernando, B. Mensel, P.C. Kruger, T. Ittermann, et al. (2014) Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging, 39(6): p. 1494-501.CrossRefPubMed Kuhn, J.P., D. Hernando, B. Mensel, P.C. Kruger, T. Ittermann, et al. (2014) Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging, 39(6): p. 1494-501.CrossRefPubMed
11.
go back to reference Hines, C.D., A. Frydrychowicz, G. Hamilton, D.L. Tudorascu, K.K. Vigen, et al. (2011) T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging, 33(4): p. 873-81.CrossRefPubMedPubMedCentral Hines, C.D., A. Frydrychowicz, G. Hamilton, D.L. Tudorascu, K.K. Vigen, et al. (2011) T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging, 33(4): p. 873-81.CrossRefPubMedPubMedCentral
12.
go back to reference Zhong, X., M.D. Nickel, S.A. Kannengiesser, B.M. Dale, B. Kiefer, et al. (2014) Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med, 72(5): p. 1353-65.CrossRefPubMed Zhong, X., M.D. Nickel, S.A. Kannengiesser, B.M. Dale, B. Kiefer, et al. (2014) Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med, 72(5): p. 1353-65.CrossRefPubMed
13.
go back to reference Bashir, M.R., E.M. Merkle, A.D. Smith, and D.T. Boll (2012) Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol, 81(2): p. e101-9. Bashir, M.R., E.M. Merkle, A.D. Smith, and D.T. Boll (2012) Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol, 81(2): p. e101-9.
14.
go back to reference Wood, J.C., P. Zhang, H. Rienhoff, W. Abi-Saab, and E.J. Neufeld (2015) Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results. Magn Reson Imaging, 33(6): p. 761-7.CrossRefPubMed Wood, J.C., P. Zhang, H. Rienhoff, W. Abi-Saab, and E.J. Neufeld (2015) Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results. Magn Reson Imaging, 33(6): p. 761-7.CrossRefPubMed
15.
go back to reference Rose, C., P. Vandevenne, E. Bourgeois, N. Cambier, and O. Ernst (2006) Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol, 77(2): p. 145-9.CrossRefPubMed Rose, C., P. Vandevenne, E. Bourgeois, N. Cambier, and O. Ernst (2006) Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol, 77(2): p. 145-9.CrossRefPubMed
16.
go back to reference Lin, H., H. Wei, N. He, C. Fu, S. Cheng, et al. (2018) Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification. Eur Radiol, 28(8): p. 3494-3504.CrossRefPubMedPubMedCentral Lin, H., H. Wei, N. He, C. Fu, S. Cheng, et al. (2018) Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification. Eur Radiol, 28(8): p. 3494-3504.CrossRefPubMedPubMedCentral
17.
go back to reference Meisamy, S., C.D. Hines, G. Hamilton, C.B. Sirlin, C.A. McKenzie, et al. (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology, 258(3): p. 767-75.CrossRefPubMedPubMedCentral Meisamy, S., C.D. Hines, G. Hamilton, C.B. Sirlin, C.A. McKenzie, et al. (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology, 258(3): p. 767-75.CrossRefPubMedPubMedCentral
18.
go back to reference Henninger, B., H. Zoller, S. Kannengiesser, X. Zhong, W. Jaschke, et al. (2017) 3D Multiecho Dixon for the Evaluation of Hepatic Iron and Fat in a Clinical Setting. J Magn Reson Imaging, 46(3): p. 793-800.CrossRefPubMed Henninger, B., H. Zoller, S. Kannengiesser, X. Zhong, W. Jaschke, et al. (2017) 3D Multiecho Dixon for the Evaluation of Hepatic Iron and Fat in a Clinical Setting. J Magn Reson Imaging, 46(3): p. 793-800.CrossRefPubMed
19.
go back to reference Wood, J.C., C. Enriquez, N. Ghugre, J.M. Tyzka, S. Carson, et al. (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood, 106(4): p. 1460-5.CrossRefPubMedPubMedCentral Wood, J.C., C. Enriquez, N. Ghugre, J.M. Tyzka, S. Carson, et al. (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood, 106(4): p. 1460-5.CrossRefPubMedPubMedCentral
20.
go back to reference Alam, M.H., D. Auger, L.A. McGill, G.C. Smith, T. He, et al. (2016) Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron. J Cardiovasc Magn Reson, 18(1): p. 40. Alam, M.H., D. Auger, L.A. McGill, G.C. Smith, T. He, et al. (2016) Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron. J Cardiovasc Magn Reson, 18(1): p. 40.
21.
go back to reference Hetterich, H., C. Bayerl, A. Peters, M. Heier, B. Linkohr, et al. (2016) Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol, 26(6): p. 1895-904.CrossRefPubMed Hetterich, H., C. Bayerl, A. Peters, M. Heier, B. Linkohr, et al. (2016) Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol, 26(6): p. 1895-904.CrossRefPubMed
22.
go back to reference Liu, C.Y., C.A. McKenzie, H. Yu, J.H. Brittain, and S.B. Reeder (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med, 58(2): p. 354-64.CrossRefPubMed Liu, C.Y., C.A. McKenzie, H. Yu, J.H. Brittain, and S.B. Reeder (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med, 58(2): p. 354-64.CrossRefPubMed
23.
go back to reference Tang, A., J. Tan, M. Sun, G. Hamilton, M. Bydder, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology, 267(2): p. 422-31.CrossRefPubMedPubMedCentral Tang, A., J. Tan, M. Sun, G. Hamilton, M. Bydder, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology, 267(2): p. 422-31.CrossRefPubMedPubMedCentral
24.
go back to reference Idilman, I.S., H. Aniktar, R. Idilman, G. Kabacam, B. Savas, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology, 267(3): p. 767-75.CrossRefPubMed Idilman, I.S., H. Aniktar, R. Idilman, G. Kabacam, B. Savas, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology, 267(3): p. 767-75.CrossRefPubMed
25.
go back to reference Franca, M., A. Alberich-Bayarri, L. Marti-Bonmati, P. Oliveira, F.E. Costa, et al. (2017) Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdom Radiol (NY), 42(5): p. 1434-1443.CrossRef Franca, M., A. Alberich-Bayarri, L. Marti-Bonmati, P. Oliveira, F.E. Costa, et al. (2017) Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdom Radiol (NY), 42(5): p. 1434-1443.CrossRef
26.
go back to reference Bashir, M.R., X. Zhong, B.M. Dale, R.T. Gupta, D.T. Boll, et al. (2013) Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI. AJR Am J Roentgenol, 201(3): p. 583-8.CrossRefPubMed Bashir, M.R., X. Zhong, B.M. Dale, R.T. Gupta, D.T. Boll, et al. (2013) Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI. AJR Am J Roentgenol, 201(3): p. 583-8.CrossRefPubMed
27.
go back to reference Galimberti, S., P. Trombini, D.P. Bernasconi, I. Redaelli, S. Pelucchi, et al. (2015) Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia. Scand J Gastroenterol, 50(4): p. 429-38.CrossRefPubMed Galimberti, S., P. Trombini, D.P. Bernasconi, I. Redaelli, S. Pelucchi, et al. (2015) Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia. Scand J Gastroenterol, 50(4): p. 429-38.CrossRefPubMed
28.
go back to reference Kuhn, J.P., D. Hernando, A. Munoz del Rio, M. Evert, S. Kannengiesser, et al. (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology, 265(1): p. 133-42.CrossRefPubMedPubMedCentral Kuhn, J.P., D. Hernando, A. Munoz del Rio, M. Evert, S. Kannengiesser, et al. (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology, 265(1): p. 133-42.CrossRefPubMedPubMedCentral
29.
go back to reference Storey, P., A.A. Thompson, C.L. Carqueville, J.C. Wood, R.A. de Freitas, et al. (2007) R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging, 25(3): p. 540-7. Storey, P., A.A. Thompson, C.L. Carqueville, J.C. Wood, R.A. de Freitas, et al. (2007) R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging, 25(3): p. 540-7.
30.
go back to reference Banerjee, R., M. Pavlides, E.M. Tunnicliffe, S.K. Piechnik, N. Sarania, et al. (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol, 60(1): p. 69-77.CrossRefPubMedPubMedCentral Banerjee, R., M. Pavlides, E.M. Tunnicliffe, S.K. Piechnik, N. Sarania, et al. (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol, 60(1): p. 69-77.CrossRefPubMedPubMedCentral
31.
go back to reference Henninger, B., H. Zoller, S. Rauch, M. Schocke, S. Kannengiesser, et al. (2015) Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences. Eur Radiol, 25(5): p. 1356-65.CrossRefPubMed Henninger, B., H. Zoller, S. Rauch, M. Schocke, S. Kannengiesser, et al. (2015) Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences. Eur Radiol, 25(5): p. 1356-65.CrossRefPubMed
32.
go back to reference Lin, H., C. Fu, S. Kannengiesser, S. Cheng, J. Shen, et al. (2018) Quantitative analysis of hepatic iron in patients suspected of coexisting iron overload and steatosis using multi-echo single-voxel magnetic resonance spectroscopy: Comparison with fat-saturated multi-echo gradient echo sequence. J Magn Reson Imaging, 48(1): p. 205-213.CrossRefPubMed Lin, H., C. Fu, S. Kannengiesser, S. Cheng, J. Shen, et al. (2018) Quantitative analysis of hepatic iron in patients suspected of coexisting iron overload and steatosis using multi-echo single-voxel magnetic resonance spectroscopy: Comparison with fat-saturated multi-echo gradient echo sequence. J Magn Reson Imaging, 48(1): p. 205-213.CrossRefPubMed
33.
go back to reference St Pierre, T.G., P.R. Clark, W. Chua-anusorn, A.J. Fleming, G.P. Jeffrey, et al. (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood, 105(2): p. 855-61.CrossRefPubMed St Pierre, T.G., P.R. Clark, W. Chua-anusorn, A.J. Fleming, G.P. Jeffrey, et al. (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood, 105(2): p. 855-61.CrossRefPubMed
Metadata
Title
Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy
Authors
Chenyang Zhan
Sonja Olsen
Hoi Cheung Zhang
Stephan Kannengiesser
Hersh Chandarana
Krishna Prasad Shanbhogue
Publication date
01-09-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 9/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02118-9

Other articles of this Issue 9/2019

Abdominal Radiology 9/2019 Go to the issue

Classics in Abdominal Radiology

“Balloons-on-strings” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.